Landscape Capital Management’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
Other funds holding MRNA
VCM
VPM
Landscape Capital Management's MRNA Position: Q1 2026 in Review
Landscape Capital Management sold out of Moderna (MRNA) in Q1 2026, closing a stake of 22,347 shares — an estimated $659K sold.
Landscape Capital Management first reported a position in MRNA in Q1 2020 and held it in 3 quarters. The position peaked at $1.05M in Q1 2020. 722 funds tracked by Wall St. Rank hold MRNA as of Q1 2026.
- Landscape Capital Management reported no remaining Moderna position as of Q1 2026 after selling out during the quarter.
- Landscape Capital Management sold 22,347 Moderna shares in Q1 2026, an estimated $659K.
- Landscape Capital Management first reported a position in Moderna in Q1 2020 and held it in 3 quarters.
- Landscape Capital Management's Moderna position peaked at $1.05M in Q1 2020.
- 722 funds tracked by Wall St. Rank held Moderna as of Q1 2026.
Based on Landscape Capital Management's 13F filing for Q1 2026, filed 12 May 2026.